OVERVIEW

Our mission is to improve the quality of life of patients suffering from neurogenic inflammation associated with numerous pathologies such as peripheral neuropathy, back pain, psoriasis, and atopic skin.

PHILOSOPHY

We strive to make our products accessible and affordable for all and everywhere.

MANAGEMENT TEAM

JF. Plucker
JF. PluckerCo-fondateur & COO
Jean François brings a seasoned experience in management, international business and intellectual property in several areas, including healthcare.
Ph. Van Wesepoel
Ph. Van WesepoelCo-fondateur & CSO
Philippe has a demonstrated expertise in R&D development and its commercial deployment in the pharmaceutical sector. He brings an international network of experts, particularly in the field of diabetes.
V. Gordenne
V. GordenneIndustrial Pharmacist
Valérie brings a deep operational and strategic knowledge in drug development, including in regulatory affairs

BOARD OF DIRECTORS

Ph. Van Wesepoel
Ph. Van WesepoelAssociate Director - CSO
OLYS Pharma
Jean François Plucker
Jean François PluckerAssociate Director - COO
OLYS Pharma
V. Gordenne
V. GordenneAdministrator
MITHRA PHARMACEUTICALS
Sébastien Gillig
Sébastien GilligVice-President Finance Europe
ECOLAB
Jean-Marie Vandeplas
Jean-Marie VandeplasCEO
COLE PHARMA